Tigatx Inc.

Boston, MA Tigatx Inc.

UEI
SJDTADABKVC7
CAGE
9TA15
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
75 Kneeland St Fl 14, Boston, MA 02111, USA
Website
tigatx.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Tigatx Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Late-stage development and DE-risking of a novel monoclonal antibody immunotherapy for egfr-positive solid cancers -… Grant · R44CA291266 National Cancer Institute $1,083,941

Quick answers

What is Tigatx Inc.'s UEI?

Tigatx Inc.'s Unique Entity ID (UEI) in SAM.gov is SJDTADABKVC7.

What is Tigatx Inc.'s CAGE code?

Tigatx Inc.'s CAGE code is 9TA15.

What is Tigatx Inc.'s primary NAICS code?

Tigatx Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Tigatx Inc. located?

Tigatx Inc.'s physical address in SAM.gov is 75 Kneeland St Fl 14, Boston, MA 02111, USA.

Is Tigatx Inc. registered in SAM.gov?

Yes. Tigatx Inc.'s SAM.gov registration is active through July 16, 2027.

What is Tigatx Inc.'s most recent federal award?

Tigatx Inc.'s most recent federal grant award is Late-stage development and DE-risking of a novel monoclonal antibody immunotherapy for egfr-positive solid cancers -… (R44CA291266), from National Cancer Institute, on September 6, 2024.

On GovTribe

See Tigatx Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors